ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported first-quarter earnings of $21.5 million.

The Rockville, Maryland-based company said it had profit of 40 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.

The drugmaker posted revenue of $95 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $85.2 million.

Supernus shares have declined slightly more than 6% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $22.22, a fall of 42% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN

Automated Insights, source Associated Press News